García-Rey C, Aguilar L, Baquero F, Casal J, Martín J E
Medical Department, GlaxoSmithKline, Tres Cantos, Spain.
J Clin Microbiol. 2002 Aug;40(8):2959-63. doi: 10.1128/JCM.40.8.2959-2963.2002.
The M phenotype is by far the most common mechanism of erythromycin resistance among Streptococcus pyogenes isolates in Spain. A geographic analysis of the relationship between within-country differences in the prevalence of M-type resistance to erythromycin in S. pyogenes and the level of consumption of 14- and 15-membered macrolides within different provinces was carried out. From 1998 to 1999, a nationwide multicenter surveillance study yielded 2,039 consecutive pharyngeal isolates of S. pyogenes. Data on antibiotic consumption for the same period were gathered from IMS Health, and the corresponding daily defined doses per 1,000 inhabitants per day were calculated according to the Anatomic Therapeutic Classification index. Macrolide use was subdivided into dosages given three times a day (TID), twice a day (BID), or once a day (OD). Spearman nonparametric correlation coefficients (R) were calculated, and variables proving to be significantly associated (P < 0.1) were introduced into a linear regression model. The total consumption of macrolides presented a significant correlation with the prevalence of resistance (R = 0.527; P = 0.032). Neither TID nor BID macrolide consumption showed significant correlations. Only OD consumption had a significance below 0.1. These data are consistent with the hypothesis that only the total consumption of macrolides influences the local rates of M-type erythromycin resistance in S. pyogenes, and subgroups of macrolides seem to have an additive rather than a selective effect by contributing to increasing the final amount of macrolides used. Local variations in total consumption were associated only with BID consumption (R = 0.849; P = 0.004). The simple linear regression with total macrolide consumption showed a considerable determination coefficient (R(2) = 0.678; P = 0.006). The model explains up to 68% of the measured variation and is clearly better as a predictor of the prevalence of resistance than the mere mean is. By solving the regression equation, the resultant value of 2.2 defined doses per 1,000 inhabitants per day fits with the existence of a critical threshold of selective pressure.
在西班牙,M表型是化脓性链球菌分离株中红霉素耐药最常见的机制。对化脓性链球菌中M型红霉素耐药率在国内不同地区的差异与不同省份14元和15元大环内酯类药物的消费水平之间的关系进行了地理分析。1998年至1999年,一项全国性多中心监测研究连续获得了2039株化脓性链球菌咽部分离株。同期抗生素消费数据从IMS Health收集,并根据解剖治疗分类指数计算每1000居民每天相应的限定日剂量。大环内酯类药物的使用分为每日三次(TID)、每日两次(BID)或每日一次(OD)给药剂量。计算了Spearman非参数相关系数(R),并将证明有显著关联(P < 0.1)的变量引入线性回归模型。大环内酯类药物的总消费量与耐药率呈显著相关性(R = 0.527;P = 0.032)。TID和BID大环内酯类药物消费均未显示出显著相关性。只有OD消费量具有低于0.1的显著性。这些数据与以下假设一致,即只有大环内酯类药物的总消费量会影响化脓性链球菌中M型红霉素耐药的局部发生率,并且大环内酯类药物的亚组似乎通过增加最终使用的大环内酯类药物总量而具有累加效应而非选择效应。总消费量的局部差异仅与BID消费量相关(R = 0.849;P = 0.004)。与大环内酯类药物总消费量的简单线性回归显示出相当大的决定系数(R² = 0.678;P = 0.006)。该模型解释了高达68%的测量变异,并且作为耐药率的预测指标明显优于单纯的平均值。通过求解回归方程,每1000居民每天2.2个限定日剂量的结果值符合选择性压力临界阈值的存在情况。